Literature DB >> 33085065

Bile Acids: A Communication Channel in the Gut-Brain Axis.

Vera F Monteiro-Cardoso1,2, Maria Corlianò1,2, Roshni R Singaraja3,4.   

Abstract

Bile acids are signalling hormones involved in the regulation of several metabolic pathways. The ability of bile acids to bind and signal through their receptors is modulated by the gut microbiome, since the microbiome contributes to the regulation and synthesis of bile acids as well to their physiochemical properties. From the gut, bacteria have been shown to send signals to the central nervous system via their metabolites, thus affecting the behaviour and brain function of the host organism. In the last years it has become increasingly evident that bile acids affect brain function, during normal physiological and pathological conditions. Although bile acids may be synthesized locally in the brain, the majority of brain bile acids are taken up from the systemic circulation. Since the composition of the brain bile acid pool may be regulated by the action of intestinal bacteria, it is possible that bile acids function as a communication bridge between the gut microbiome and the brain. However, little is known about the molecular mechanisms and the physiological roles of bile acids in the central nervous system. The possibility that bile acids may be a direct link between the intestinal microbiome and the brain is also an understudied subject. Here we review the influence of gut bacteria on the bile acid pool composition and properties, as well as striking evidence showing the role of bile acids as neuroactive molecules.

Entities:  

Keywords:  Bile acids; Gut microbiome; Gut-brain axis; Neurodegenerative disorders

Year:  2020        PMID: 33085065     DOI: 10.1007/s12017-020-08625-z

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  122 in total

Review 1.  Bile salt hydrolase activity in probiotics.

Authors:  Máire Begley; Colin Hill; Cormac G M Gahan
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

Review 2.  Gut microbiota, immune development and function.

Authors:  Stig Bengmark
Journal:  Pharmacol Res       Date:  2012-09-16       Impact factor: 7.658

3.  DCA can improve the ACI-induced neurological impairment through negative regulation of Nrf2 signaling pathway.

Authors:  K-Y Bian; H-F Jin; W Sun; Y-J Sun
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-01       Impact factor: 3.507

4.  Treatment with chenodeoxycholic acid in cerebrotendinous xanthomatosis: clinical, neurophysiological, and quantitative brain structural outcomes.

Authors:  Maria Del Mar Amador; Marion Masingue; Rabab Debs; Foudil Lamari; Vincent Perlbarg; Emmanuel Roze; Bertrand Degos; Fanny Mochel
Journal:  J Inherit Metab Dis       Date:  2018-03-20       Impact factor: 4.982

5.  Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum.

Authors:  B Angelin; I Björkhem; K Einarsson; S Ewerth
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

6.  Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4.

Authors:  Zhihong Chen; Walid Jalabi; Karl B Shpargel; Kenneth T Farabaugh; Ranjan Dutta; Xinghua Yin; Grahame J Kidd; Cornelia C Bergmann; Stephen A Stohlman; Bruce D Trapp
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

Review 7.  Huntington disease.

Authors:  Gillian P Bates; Ray Dorsey; James F Gusella; Michael R Hayden; Chris Kay; Blair R Leavitt; Martha Nance; Christopher A Ross; Rachael I Scahill; Ronald Wetzel; Edward J Wild; Sarah J Tabrizi
Journal:  Nat Rev Dis Primers       Date:  2015-04-23       Impact factor: 52.329

8.  Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.

Authors:  M Castro-Caldas; A Neves Carvalho; E Rodrigues; C J Henderson; C R Wolf; C M P Rodrigues; M J Gama
Journal:  Mol Neurobiol       Date:  2012-07-08       Impact factor: 5.590

9.  CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.

Authors:  Lydie Boussicault; Sandro Alves; Antonin Lamazière; Anabelle Planques; Nicolas Heck; Lara Moumné; Gaëtan Despres; Susanne Bolte; Amélie Hu; Christiane Pagès; Laurie Galvan; Francoise Piguet; Patrick Aubourg; Nathalie Cartier; Jocelyne Caboche; Sandrine Betuing
Journal:  Brain       Date:  2016-01-29       Impact factor: 13.501

Review 10.  Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies.

Authors:  Francisco J Carvajal; Hayley A Mattison; Waldo Cerpa
Journal:  Neural Plast       Date:  2016-08-18       Impact factor: 3.599

View more
  20 in total

1.  Maternal term pruritus and long-term neuropsychiatric hospitalizations of the offspring.

Authors:  Omer Levanony; Eyal Sheiner; Dvora Kluwgant; Gali Pariente
Journal:  Arch Gynecol Obstet       Date:  2022-08-30       Impact factor: 2.493

Review 2.  Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review.

Authors:  Raghunath Singh; Nicolette Stogios; Emily Smith; Jiwon Lee; Kateryna Maksyutynsk; Emily Au; David C Wright; Giada De Palma; Ariel Graff-Guerrero; Philip Gerretsen; Daniel J Müller; Gary Remington; Margaret Hahn; Sri Mahavir Agarwal
Journal:  Ther Adv Psychopharmacol       Date:  2022-05-15

3.  Metabolic Pathways Associated With Psychoneurological Symptoms in Children With Cancer Receiving Chemotherapy.

Authors:  Jinbing Bai; Janice Withycombe; Ronald C Eldridge
Journal:  Biol Res Nurs       Date:  2022-03-12       Impact factor: 2.318

Review 4.  Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease.

Authors:  Davide Banfi; Elisabetta Moro; Annalisa Bosi; Michela Bistoletti; Silvia Cerantola; Francesca Crema; Fabrizio Maggi; Maria Cecilia Giron; Cristina Giaroni; Andreina Baj
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

5.  Microbiota and Metabolite Profiling as Markers of Mood Disorders: A Cross-Sectional Study in Obese Patients.

Authors:  Quentin Leyrolle; Renata Cserjesi; Romane Demeure; Audrey M Neyrinck; Camille Amadieu; Julie Rodriguez; Olli Kärkkäinen; Kati Hanhineva; Nicolas Paquot; Miriam Cnop; Patrice D Cani; Jean-Paul Thissen; Laure B Bindels; Olivier Klein; Olivier Luminet; Nathalie M Delzenne
Journal:  Nutrients       Date:  2021-12-29       Impact factor: 5.717

Review 6.  The Microbiota and the Gut-Brain Axis in Controlling Food Intake and Energy Homeostasis.

Authors:  Marina Romaní-Pérez; Clara Bullich-Vilarrubias; Inmaculada López-Almela; Rebeca Liébana-García; Marta Olivares; Yolanda Sanz
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

7.  Obeticholic Acid Inhibits Anxiety via Alleviating Gut Microbiota-Mediated Microglia Accumulation in the Brain of High-Fat High-Sugar Diet Mice.

Authors:  Li Wu; Yuqiu Han; Zhipeng Zheng; Shuai Zhu; Jun Chen; Yuanyuan Yao; Siqing Yue; Andreas Teufel; Honglei Weng; Lanjuan Li; Baohong Wang
Journal:  Nutrients       Date:  2021-03-15       Impact factor: 5.717

Review 8.  Gut Microbiota Metabolites in Major Depressive Disorder-Deep Insights into Their Pathophysiological Role and Potential Translational Applications.

Authors:  Miguel A Ortega; Miguel Angel Alvarez-Mon; Cielo García-Montero; Oscar Fraile-Martinez; Luis G Guijarro; Guillermo Lahera; Jorge Monserrat; Paula Valls; Fernando Mora; Roberto Rodríguez-Jiménez; Javier Quintero; Melchor Álvarez-Mon
Journal:  Metabolites       Date:  2022-01-08

Review 9.  Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease.

Authors:  Agata Mulak
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 10.  A Recent Ten-Year Perspective: Bile Acid Metabolism and Signaling.

Authors:  Yulia Shulpekova; Elena Shirokova; Maria Zharkova; Pyotr Tkachenko; Igor Tikhonov; Alexander Stepanov; Alexandra Sinitsyna; Alexander Izotov; Tatyana Butkova; Nadezhda Shulpekova; Vladimir Nechaev; Igor Damulin; Alexey Okhlobystin; Vladimir Ivashkin
Journal:  Molecules       Date:  2022-03-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.